SEP 11, 2019 10:52 AM PDT

Insulin Drug Could Treat Glioblastoma

WRITTEN BY: Nouran Amin

A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold treatment capabilities for an aggressive and fatal form of brain cancer—glioblastoma.

Glioblastoma is a fast-growing tumor that arises from supportive tissue around the brain that eventually resist any surgical treatment. The tumor cells become challenging to remove when it is surrounded by healthy brain tissue. More than half of all new cases pass away within the first 15 months. However, the death of late U.S. Sens. John McCain and Ted Kennedy have brought national awareness to that particular cancer and more research attention.

Learn more about glioblastoma:

Now, researchers at the University of Georgia (UGA), discovered that ‘surfen’--a compound first introduced in 1938—is a pharmaceutical agent for optimizing insulin delivery. The researchers described that surfen-treated cells did not further the tumor growth or the the spread of tumor cells.

The MRI image shows the effects of the surfen treatment] pretty drastically.The non-treated image indicates see rampant invasive growth in comparison to the surfen-models where you see a contained tumor.”

Image Credit UGA.edu

“This study shows that we can stifle the growth of invasive brain tumors with a compound that has a substantial clinical advantage, and can aid in the reduction or refinement of mainstream treatments, particularly radiation and/or chemo,” said Lohitash Karumbaiah, associate professor of regenerative medicine in UGA’s College of Agricultural and Environmental Sciences.

Findings of the study were reported in the FASEB Journal. It was the first to report the use of surfen as an application for the treatment of glioblastoma.

“In basic terms, surfen is highly positively charged and will bind to negatively charged things,” said Meghan Logun, a graduate student working with Karumbaiah. “Since we study sugars in the brain, which are highly negatively charged, we then asked, ‘Why not try using positive charges to block off the negative ones? In the surfen-treated animals, we saw that the tumors were actually much more constrained and had more defined boundaries.”

From UGA.edu: Lohitash Karumbaiah at work in his lab. (Photo by Dorothy Kozlowski/UGA)

“The tumor may still grow, but at least now it doesn’t have any invasive inroads to creep into other parts of the brain,” said Karumbaiah. “That could be clinically beneficial for a surgeon wanting to remove the tumor and not having to worry about rogue cancer cells. Our hope is that, in the wake of this discovery, lives can be saved, and we can finally change the scope of this life-threatening disease.”

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
IV Treatment for Traumatic Brain Injury
Scientists are now using exosomes intravenously as a method of cell-to-cell technology for treating patients with traumatic brain injury (TBI). They discov...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 20, 2020
Cancer
JAN 20, 2020
Did you know these non-cancer drugs can also fight cancer?
A study from MIT. Harvard and the Dana-Farber Cancer Institute has concluded that almost 50 existing non-oncological drugs have anti-cancer properties capa...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 23, 2020
Drug Discovery & Development
FEB 23, 2020
Drug Preserves Brain Cells
Can we preserve brain cells even after years of hopeless research? Apparently, yes—according to a recent study published in the Lancet treating patie...
Loading Comments...